Status and phase
Conditions
Treatments
Study type
Funder types
Identifiers
About
The purpose of this long-term follow-up study is to assess the long-term health status of HIV-infected subjects who previously participated in GSK-sponsored trials evaluating the investigational HIV vaccine 732462. This study will provide additional data concerning the long-term benefits/risks associated with vaccination.
No vaccine will be administered during the study period. Vaccines were administered during the primary studies.
Full description
General information on the health of the subject and persistence of the cellular and humoral immune responses to study vaccination will be evaluated.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
All subjects must satisfy ALL the following criteria at study entry:
Exclusion criteria
The following criteria should be checked at the time of study entry. If ANY exclusion criterion applies, the subject must not be included in the study:
• Subjects who did not receive a complete vaccination course in previous studies.
Primary purpose
Allocation
Interventional model
Masking
190 participants in 2 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal